Journal of Infusion Nursing最新文献_第10页

Changing the Buffer in Buffered Lidocaine. 改变缓冲利多卡因中的缓冲液。

IF 2

Journal of Infusion Nursing Pub Date : 2022-09-01 DOI: 10.1097/NAN.0000000000000481

Ann Plohal, Eric P Dutchover, Jennifer Root, Brian Kurilla, Randy Balas

{"title":"Changing the Buffer in Buffered Lidocaine.","authors":"Ann Plohal, Eric P Dutchover, Jennifer Root, Brian Kurilla, Randy Balas","doi":"10.1097/NAN.0000000000000481","DOIUrl":"https://doi.org/10.1097/NAN.0000000000000481","url":null,"abstract":"Hospitalized patients require venous access for procedures, treatments, or therapies. The use of lidocaine for pain relief during central vascular access device (CVAD) insertion is a standard of practice. Lidocaine buffered with sodium bicarbonate has been shown to provide significantly more pain relief in the sensation of pain upon injection. Shortages of lidocaine with bicarbonate provided an opportunity to explore other options to provide pain relief during CVAD insertion. The PICO question for this project was: In adult patients requiring CVAD insertion, how does lidocaine buffered with bicarbonate compare with lidocaine buffered with saline in minimizing pain with lidocaine injection? This study assessed how lidocaine buffered with bicarbonate compares with lidocaine buffered with saline in minimizing pain with lidocaine injection. Sixty patients received the buffered lidocaine before having a peripherally inserted central catheter inserted. Thirty patients received lidocaine buffered with bicarbonate and 30 patients received lidocaine buffered with saline. Pain and vasoconstriction were the 2 outcomes monitored during the project. Although the trial was only 2 wk due to the urgency of the rollout, the pilot was able to offer clinicians the opportunity to compare the 2 products. The saline-buffered lidocaine provided comparable pain relief compared with the lidocaine buffered with bicarbonate. The clinicians also measured the amount of vasoconstriction caused by the 2 products with similar outcomes.","PeriodicalId":46291,"journal":{"name":"Journal of Infusion Nursing","volume":"45 5","pages":"245-251"},"PeriodicalIF":2.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40363136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A Retrospective Assessment of Midline Catheter Failures Focusing on Catheter Composition. 以导管组成为中心的中线导管失效回顾性评估。

IF 2

Journal of Infusion Nursing Pub Date : 2022-09-01 DOI: 10.1097/NAN.0000000000000484

Joseph Bunch

{"title":"A Retrospective Assessment of Midline Catheter Failures Focusing on Catheter Composition.","authors":"Joseph Bunch","doi":"10.1097/NAN.0000000000000484","DOIUrl":"https://doi.org/10.1097/NAN.0000000000000484","url":null,"abstract":"Vascular access specialists are responsible for assessing the patient in their unique situation and determining the correct vascular access device to complete the therapeutic goal without complication or failure. This retrospective cohort study compared the failure rates of a variety of polyurethane (PU) midline catheters and a midline catheter constructed of an emerging hydrophilic biomaterial (HBM). A total of 205 patients received a midline catheter and were situationally randomized by the facility where they received it. Patients who had received a midline catheter between March 2021 and May 2021 were assessed for catheter-related failures leading to increased staff time, delays in treatment, or replacement with a new vascular access device to complete the therapy. There were 101 patients in the PU cohort and 104 patients in the HBM cohort. Comparing overall failure rates between the groups revealed a 23.8% failure rate in the PU control group and only a 3.8% failure rate in the HBM group. This suggests that a midline catheter constructed of HBM biomaterial is associated with significantly lower rates of failure, thereby improving patient experience and health care economics.","PeriodicalId":46291,"journal":{"name":"Journal of Infusion Nursing","volume":"45 5","pages":"270-278"},"PeriodicalIF":2.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40363141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3

Transparency in Error Reporting. 错误报告的透明度。

IF 2

Journal of Infusion Nursing Pub Date : 2022-09-01 DOI: 10.1097/NAN.0000000000000485

Mary Alexander

引用次数: 0

Transfusion-Associated Adverse Events: A Case Report of Nurse Hemovigilance and Recognition of Respiratory Distress. 输血相关不良事件:1例护士血液警觉与呼吸窘迫识别报告。

IF 2

Journal of Infusion Nursing Pub Date : 2022-09-01 DOI: 10.1097/NAN.0000000000000483

Nicole C Lea, Karen Gibbs, Chantay Johnson, Anne Lam, Elizabeth Wuestner, Shiu-Ki Rocky Hui

{"title":"Transfusion-Associated Adverse Events: A Case Report of Nurse Hemovigilance and Recognition of Respiratory Distress.","authors":"Nicole C Lea, Karen Gibbs, Chantay Johnson, Anne Lam, Elizabeth Wuestner, Shiu-Ki Rocky Hui","doi":"10.1097/NAN.0000000000000483","DOIUrl":"https://doi.org/10.1097/NAN.0000000000000483","url":null,"abstract":"Although blood transfusions are considered a potentially life-saving therapy, noninfectious and infectious adverse events can lead to significant morbidities and even mortality. Vital signs and visual observation of patients during blood transfusions are thoroughly taught in nursing school. Updated terms of hemovigilance and transfusion-associated adverse events ( TAAEs ) are presented through this case study. A patient with factor V deficiency, which requires chronic plasma transfusions, experienced 2 types of TAAEs, anaphylaxis and transfusion-associated circulatory overload. The patient's history and TAAEs are presented and discussed to provide evidence for the importance of vigilant bedside surveillance. Early identification of TAAEs may prevent unnecessary morbidity and/or mortality. The primary nursing functions and responsibilities are presented with algorithmic supplementation to facilitate better understanding of best practice. Ongoing assessment of hemovigilance practices is indicated to ascertain which monitoring tools can lead to optimal patient care.","PeriodicalId":46291,"journal":{"name":"Journal of Infusion Nursing","volume":"45 5","pages":"264-269"},"PeriodicalIF":2.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40363140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Implementation of an Evidence-Based Practice Change Removing Heparin From Implanted Vascular Access Devices. 从植入血管通路装置中去除肝素的循证实践改变的实施。

IF 2

Journal of Infusion Nursing Pub Date : 2022-09-01 DOI: 10.1097/NAN.0000000000000482

Megan Hoffman, Erica Fischer-Cartlidge

引用次数: 0

Patient Experience With Vascular Access Management Informs Satisfaction With Overall Hospitalization Experience: Erratum. 患者对血管通路管理的体验反映了对整体住院体验的满意度：勘误。

IF 2.9

Journal of Infusion Nursing Pub Date : 2022-07-01 DOI: 10.1097/NAN.0000000000000474

引用次数: 0

2021 INS Financial Report. 2021年INS财务报告。

IF 2

Journal of Infusion Nursing Pub Date : 2022-07-01 DOI: 10.1097/NAN.0000000000000475

Joan Couden

引用次数: 0

Development of a Quality Assessment Tool for Outpatient Infusion Clinics: A Literature Review and Pilot Survey 门诊输液临床质量评估工具的开发：文献综述和初步调查

IF 2

Journal of Infusion Nursing Pub Date : 2022-05-01 DOI: 10.1097/NAN.0000000000000466

Ella Hu, Maryam Shams, Daniel Shirvani, M. Badii

{"title":"Development of a Quality Assessment Tool for Outpatient Infusion Clinics: A Literature Review and Pilot Survey","authors":"Ella Hu, Maryam Shams, Daniel Shirvani, M. Badii","doi":"10.1097/NAN.0000000000000466","DOIUrl":"https://doi.org/10.1097/NAN.0000000000000466","url":null,"abstract":"This study aimed to develop a quality assessment tool for outpatient infusion clinics, as a lack of literature exists on the subject. The authors conducted a literature review targeting studies since 2016 to identify variables that affect patient satisfaction in outpatient infusion clinics. Due to the limited number of relevant studies found, the authors shadowed 2 infusion clinic nurses to capture additional determinants of outpatient infusion clinic quality. A total of 72 variables relevant to an outpatient infusion quality assessment tool were listed. From this list of variables, a pilot survey was conducted at an outpatient rheumatology infusion clinic to assess patient satisfaction with 16 variables of interest. The pilot survey (N = 43) revealed that patients were relatively dissatisfied with walking to clinics, lack of access to public transit, lack of parking and/or free parking, lack of privacy, and flexible scheduling and/or cancellation policies. These findings demonstrate how the assessment tool may highlight specific areas of concern at an infusion clinic to identify targets for future quality improvement initiatives. Therefore, the tool presented has the potential to improve the quality of care provided to patients attending infusion facilities.","PeriodicalId":46291,"journal":{"name":"Journal of Infusion Nursing","volume":"45 1","pages":"165 - 175"},"PeriodicalIF":2.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42476001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

It Never Gets Old. 它永远不会老。

IF 2

Journal of Infusion Nursing Pub Date : 2022-05-01 DOI: 10.1097/NAN.0000000000000470

M. Alexander

引用次数: 0

Avelumab First-Line Maintenance Treatment in Advanced Bladder Cancer: Practical Implementation Steps for Infusion Nurses. 晚期膀胱癌的Avelumab一线维持治疗:输液护士的实际实施步骤。

IF 2

Journal of Infusion Nursing Pub Date : 2022-05-01 DOI: 10.1097/NAN.0000000000000465

Laura S Wood, Dawn Conway, Maria Lapuente, George Salvador, Sheila Fernandez Gomez, Andrea Carroll Bullock, Geeta Devgan, Kathleen D Burns

{"title":"Avelumab First-Line Maintenance Treatment in Advanced Bladder Cancer: Practical Implementation Steps for Infusion Nurses.","authors":"Laura S Wood, Dawn Conway, Maria Lapuente, George Salvador, Sheila Fernandez Gomez, Andrea Carroll Bullock, Geeta Devgan, Kathleen D Burns","doi":"10.1097/NAN.0000000000000465","DOIUrl":"https://doi.org/10.1097/NAN.0000000000000465","url":null,"abstract":"Immune checkpoint inhibitors, such as programmed cell death ligand 1 inhibitors pembrolizumab, nivolumab, atezolizumab, and avelumab, are used to treat patients with advanced urothelial carcinoma (UC). Based on data from the phase 3 JAVELIN Bladder 100 trial, avelumab first-line (1L) maintenance is now considered the standard-of-care treatment for patients with locally advanced or metastatic UC who responded or experienced disease stabilization after 1L platinum-containing chemotherapy, and it is the only category 1 preferred checkpoint inhibitor maintenance option in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology for patients with cisplatin-eligible and cisplatin-ineligible locally advanced or metastatic UC. This article reviews key considerations related to avelumab 1L maintenance therapy that infusion nurses should be familiar with, including dosing, administration, and immune-related adverse event recognition and management, to ensure safe and appropriate use of this important and impactful therapy.","PeriodicalId":46291,"journal":{"name":"Journal of Infusion Nursing","volume":"45 3","pages":"142-153"},"PeriodicalIF":2.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/79/9d/jinfn-45-142.PMC9071022.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10099515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 2